Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study

(1) Background: Favipiravir (FVP) is a new antiviral drug used to treat COVID-19. It has been authorized to be used in the kingdom of Saudi Arabia in the treatment of COVID-19. The mechanism of action of FVP is working as a specific inhibitor for the RNA-dependent RNA polymerase of the RNA chain vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Almutairi, Amal Oweid, El-Readi, Mahmoud Zaki, Althubiti, Mohammad, Alhindi, Yosra Zakariyya, Ayoub, Nahla, Alzahrani, Abdullah R., Al-Ghamdi, Saeed S., Eid, Safaa Yehia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966436/
https://www.ncbi.nlm.nih.gov/pubmed/36828545
http://dx.doi.org/10.3390/tropicalmed8020129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966436/
https://www.ncbi.nlm.nih.gov/pubmed/36828545
http://dx.doi.org/10.3390/tropicalmed8020129

Ejemplares similares